Molecular mechanism of down-regulating adipogenic transcription factors in 3T3-L1 adipocyte cells by bioactive anti-adipogenic compounds

Mol Biol Rep. 2021 Jan;48(1):743-761. doi: 10.1007/s11033-020-06036-8. Epub 2020 Dec 4.

Abstract

Obesity is growing at an alarming rate, which is characterized by increased adipose tissue. It increases the probability of many health complications, such as diabetes, arthritis, cardiac disease, and cancer. In modern society, with a growing population of obese patients, several individuals have increased insulin resistance. Herbal medicines are known as the oldest method of health care treatment for obesity-related secondary health issues. Several traditional medicinal plants and their effective phytoconstituents have shown anti-diabetic and anti-adipogenic activity. Adipose tissue is a major site for lipid accumulation as well as the whole-body insulin sensitivity region. 3T3-L1 cell line model can achieve adipogenesis. Adipocyte characteristics features such as expression of adipocyte markers and aggregation of lipids are chemically induced in the 3T3-L1 fibroblast cell line. Differentiation of 3T3-L1 is an efficient and convenient way to obtain adipocyte like cells in experimental studies. Peroxisome proliferation activated receptor γ (PPARγ) and Cytosine-Cytosine-Adenosine-Adenosine-Thymidine/Enhancer-binding protein α (CCAAT/Enhancer-binding protein α or C/EBPα) are considered to be regulating adipogenesis at the early stage, while adiponectin and fatty acid synthase (FAS) is responsible for the mature adipocyte formation. Excess accumulation of these adipose tissues and lipids leads to obesity. Thus, investigating adipose tissue development and the underlying molecular mechanism is important in the therapeutical approach. This review describes the cellular mechanism of 3T3-L1 fibroblast cells on potential anti-adipogenic herbal bioactive compounds.

Keywords: 3T3-L1 fibroblast; Adipocyte; Anti-adipogenic activity; Bioactive herbal compounds; Obesity.

Publication types

  • Review

MeSH terms

  • 3T3-L1 Cells
  • Adipogenesis / drug effects
  • Adipogenesis / genetics
  • Adiponectin / genetics
  • Adiponectin / metabolism
  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Adipose Tissue / pathology
  • Animals
  • Anti-Obesity Agents / chemistry
  • Anti-Obesity Agents / therapeutic use*
  • Arthritis / etiology
  • Arthritis / genetics
  • Arthritis / pathology
  • Arthritis / prevention & control*
  • CCAAT-Enhancer-Binding Proteins / genetics
  • CCAAT-Enhancer-Binding Proteins / metabolism
  • Diabetes Mellitus / etiology
  • Diabetes Mellitus / genetics
  • Diabetes Mellitus / pathology
  • Diabetes Mellitus / prevention & control*
  • Fatty Acid Synthases / genetics
  • Fatty Acid Synthases / metabolism
  • Gene Expression Regulation
  • Heart Diseases / etiology
  • Heart Diseases / genetics
  • Heart Diseases / pathology
  • Heart Diseases / prevention & control*
  • Humans
  • Insulin Resistance
  • Mice
  • Neoplasms / etiology
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Neoplasms / prevention & control*
  • Obesity / complications
  • Obesity / drug therapy*
  • Obesity / genetics
  • Obesity / pathology
  • PPAR gamma / genetics
  • PPAR gamma / metabolism
  • Phytochemicals / chemistry
  • Phytochemicals / therapeutic use*

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Anti-Obesity Agents
  • CCAAT-Enhancer-Binding Proteins
  • CEBPA protein, human
  • PPAR gamma
  • PPARG protein, human
  • Phytochemicals
  • Fatty Acid Synthases